Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AVCO Stock Forecast 2025-2026
$2.55
Current Price
$253.00M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to AVCO Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
AVCO Price Momentum
-9.6%
1 Week Change
-25.2%
1 Month Change
+431.3%
1 Year Change
-25.7%
Year-to-Date Change
-78.1%
From 52W High of $11.66
+1,478.0%
From 52W Low of $0.16
📊 TOP ANALYST CALLS
Did AVCO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Avalon is one of their latest high-conviction picks.
Latest AVCO Stock Price Targets & Analyst Predictions
AVCO has shown a year-to-date change of -25.7% and a 1-year change of 431.3%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for AVCO. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AVCO Analyst Ratings
0
Buy
0
Hold
0
Sell
AVCO Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $2.55
Latest AVCO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AVCO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Avalon GloboCare Corp (AVCO) Competitors
The following stocks are similar to Avalon based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
AVCO
Avalon GloboCare
mkt cap
265.90M
Avalon GloboCare Corp (AVCO) Financial Data
Avalon GloboCare Corp has a market capitalization of $253.00M with a P/E ratio of -2.3x. The company generates $1.39M in trailing twelve-month revenue with a 29.8% profit margin.
Revenue growth is +9.1% quarter-over-quarter, while maintaining an operating margin of N/A and return on equity of +17.7%.
Valuation Metrics
Market Cap
$253.00M
Enterprise Value
$255.49M
P/E Ratio
-2.3x
PEG Ratio
0.1x
Price/Sales
181.9x
Growth & Margins
Revenue Growth (YoY)
+9.1%
Gross Margin
+22.1%
Operating Margin
N/A
Net Margin
+29.8%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+15.9%
Current Ratio
29.9x
Debt/Equity
-0.1x
ROE
+17.7%
ROA
-88.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Avalon GloboCare Corp (AVCO) Business Model
About Avalon GloboCare Corp
What They Do
Business Model
Additional Information
Company Information
Sector
Industry
Employees
0
CEO
Country
United States
IPO Year
2016
Website
www.avalon-globocare.comAvalon GloboCare Corp (AVCO) Latest News & Analysis
Latest News
Quick Summary
The company will start trading under the new ticker symbol "ALBT" on November 10, 2022.
Why It Matters
The new trading symbol "ALBT" could signal a rebranding or strategic shift, potentially affecting investor perceptions and trading volumes. Monitor for price volatility and market sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
The company plans to acquire a majority stake in Laboratory Services MSO, LLC, which reported over $25 million in revenue and over $10 million in net income in 2021.
Why It Matters
The acquisition of a profitable laboratory with significant revenue and testing volume suggests potential growth and increased market share, positively impacting future financial performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Avalon GloboCare Corp (NASDAQ:AVCO) received a notice of allowance from the USPTO for its QTY fusion water-soluble receptor protein platform, enhancing drug development potential.
Why It Matters
Avalon GloboCare's patent allowance for its QTY technology enhances its competitive edge, potentially driving innovation in drug development and attracting investor interest in future growth.
Source: Proactive Investors
Market Sentiment:
Neutral
Quick Summary
The Company, in collaboration with MIT, has submitted a new U.S. patent application for QTY glucose transporters.
Why It Matters
The patent application suggests potential innovation in glucose transporters, which could lead to new products or therapies, impacting future revenue and competitive positioning.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
The stock market experienced notable activity today. Additionally, three penny stocks are highlighted for potential investment this week.
Why It Matters
Stock market updates and penny stock recommendations signal market trends and potential investment opportunities, influencing trading strategies and portfolio adjustments.
Source: PennyStocks
Market Sentiment:
Positive
Avalon GloboCare says its co-developed QTY code protein code technology featured in Chemical Reviews
2 years ago
Quick Summary
Avalon GloboCare Corp (NASDAQ:AVCO) announced that its QTY protein technology was featured in Chemical Reviews, highlighting its potential for generating water-soluble proteins for biomedical uses.
Why It Matters
Avalon GloboCare's publication in a prestigious journal highlights its innovation in protein technology, potentially boosting credibility and attracting investment interest in its biomedical applications.
Source: Proactive Investors
Market Sentiment:
Positive
Frequently Asked Questions About AVCO Stock
What is Avalon GloboCare Corp's (AVCO) stock forecast for 2026?
Analyst forecasts for Avalon GloboCare Corp (AVCO) are not currently available. The stock is trading at $2.55.
Is AVCO stock a good investment in 2026?
Analyst ratings for AVCO are not currently available. The stock is currently trading at $2.55. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AVCO stock?
Price predictions from Wall Street analysts for AVCO are not currently available. The stock is trading at $2.55.
What is Avalon GloboCare Corp's business model?
N/A
What is the highest forecasted price for AVCO Avalon GloboCare Corp?
Price targets from Wall Street analysts for AVCO are not currently available. The stock is trading at $2.55.
What is the lowest forecasted price for AVCO Avalon GloboCare Corp?
Price targets from Wall Street analysts for AVCO are not currently available. The stock is trading at $2.55.
What is the overall AVCO consensus from analysts for Avalon GloboCare Corp?
Analyst ratings for AVCO are not currently available. The stock is trading at $2.55.
How accurate are AVCO stock price projections?
Stock price projections, including those for Avalon GloboCare Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 8, 2025 2:44 AM UTC